Belluscura PLC - London-headquartered medical device developer - Updates regarding offer for TMT Acquisition PLC. Agrees to increase the number of new Belluscura shares to be offered in exchange for TMT acquisition shares. TMT considers the revised terms fair and reasonable and recommends shareholders accept. Under the increased terms TMT shareholders will receive: 1 new Belluscura share in exchange for every TMT Acquisition share.

Current stock price: 17.00 pence, down 19% in London on Friday

12-month change: down 65%

Copyright 2024 Alliance News Ltd. All Rights Reserved.